Healthcare expenditure on prescribed medicines in Germany has shown a fluctuating trend over the past decade. In 2013, the expenditure stood at 12.33 units, peaking at 12.8 units in 2014 before experiencing a general decline. The year 2023 recorded an expenditure of 11.59 units. The year-on-year variation has mostly been negative since 2014, with noticeable declines in 2019 (-4.09%) and smaller decreases of less than 1% each year from 2020 to 2023. The five-year Compound Annual Growth Rate (CAGR) leading up to 2023 is -1.44%, indicating a consistent decrease in spending during this period.
Future expenditure forecasts suggest a continued slight decline through 2028, with a forecasted five-year CAGR of -0.26% and an overall forecasted five-year growth rate of -1.3%.
Future trends to watch for:
- Ongoing declines in prescription medicine expenditure, albeit at a decelerating rate.
- Potential policy changes in healthcare funding and reimbursement structures.
- Impact of new pharmaceutical innovations and generic medication adoption.
- Population aging and demographic shifts influencing healthcare demands.
